The global Paracetamol Active Pharmaceutical Ingredients market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Mallinckrodt Pharmaceuticals
Anqiu Luan Pharmaceutical
Novacyl
BASF
Anhui BBCA Pharmaceuticals
Hubei Biocause
Xinhua Pharm
Granules India Limited
Huagang Pharm
Hebei Jiheng Pharmaceutical
Zhejiang Kangle Pharmaceutical
By Types:
Purity (99%-99.5%)
Purity (above 99.5%)
Purity (below 99 %)
By Applications:
Headache and Fever
Cold and Cough
Muscle Cramps
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Paracetamol Active Pharmaceutical Ingredients Market Size Analysis from 2023 to 2028
1.5.1 Global Paracetamol Active Pharmaceutical Ingredients Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Paracetamol Active Pharmaceutical Ingredients Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Paracetamol Active Pharmaceutical Ingredients Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Paracetamol Active Pharmaceutical Ingredients Industry Impact
Chapter 2 Global Paracetamol Active Pharmaceutical Ingredients Competition by Types, Applications, and Top Regions and Countries
2.1 Global Paracetamol Active Pharmaceutical Ingredients (Volume and Value) by Type
2.1.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption and Market Share by Type (2017-2022)
2.1.2 Global Paracetamol Active Pharmaceutical Ingredients Revenue and Market Share by Type (2017-2022)
2.2 Global Paracetamol Active Pharmaceutical Ingredients (Volume and Value) by Application
2.2.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption and Market Share by Application (2017-2022)
2.2.2 Global Paracetamol Active Pharmaceutical Ingredients Revenue and Market Share by Application (2017-2022)
2.3 Global Paracetamol Active Pharmaceutical Ingredients (Volume and Value) by Regions
2.3.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Paracetamol Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption by Regions (2017-2022)
4.2 North America Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
4.10 South America Paracetamol Active Pharmaceutical Ingredients Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Paracetamol Active Pharmaceutical Ingredients Market Analysis
5.1 North America Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
5.1.1 North America Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
5.2 North America Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
5.3 North America Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
5.4 North America Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
5.4.1 United States Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
5.4.2 Canada Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
5.4.3 Mexico Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 6 East Asia Paracetamol Active Pharmaceutical Ingredients Market Analysis
6.1 East Asia Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
6.1.1 East Asia Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
6.2 East Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
6.3 East Asia Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
6.4 East Asia Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
6.4.1 China Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
6.4.2 Japan Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
6.4.3 South Korea Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 7 Europe Paracetamol Active Pharmaceutical Ingredients Market Analysis
7.1 Europe Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
7.1.1 Europe Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
7.2 Europe Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
7.3 Europe Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
7.4 Europe Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
7.4.1 Germany Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.2 UK Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.3 France Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.4 Italy Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.5 Russia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.6 Spain Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.7 Netherlands Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.8 Switzerland Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
7.4.9 Poland Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 8 South Asia Paracetamol Active Pharmaceutical Ingredients Market Analysis
8.1 South Asia Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
8.1.1 South Asia Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
8.2 South Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
8.3 South Asia Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
8.4 South Asia Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
8.4.1 India Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
8.4.2 Pakistan Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Market Analysis
9.1 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
9.1.1 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
9.2 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
9.3 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
9.4 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
9.4.1 Indonesia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.2 Thailand Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.3 Singapore Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.4 Malaysia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.5 Philippines Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.6 Vietnam Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
9.4.7 Myanmar Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 10 Middle East Paracetamol Active Pharmaceutical Ingredients Market Analysis
10.1 Middle East Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
10.1.1 Middle East Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
10.2 Middle East Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
10.3 Middle East Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
10.4 Middle East Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
10.4.1 Turkey Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.3 Iran Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.5 Israel Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.6 Iraq Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.7 Qatar Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.8 Kuwait Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
10.4.9 Oman Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 11 Africa Paracetamol Active Pharmaceutical Ingredients Market Analysis
11.1 Africa Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
11.1.1 Africa Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
11.2 Africa Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
11.3 Africa Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
11.4 Africa Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
11.4.1 Nigeria Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
11.4.2 South Africa Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
11.4.3 Egypt Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
11.4.4 Algeria Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
11.4.5 Morocco Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 12 Oceania Paracetamol Active Pharmaceutical Ingredients Market Analysis
12.1 Oceania Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
12.2 Oceania Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
12.3 Oceania Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
12.4 Oceania Paracetamol Active Pharmaceutical Ingredients Consumption by Top Countries
12.4.1 Australia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
12.4.2 New Zealand Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 13 South America Paracetamol Active Pharmaceutical Ingredients Market Analysis
13.1 South America Paracetamol Active Pharmaceutical Ingredients Consumption and Value Analysis
13.1.1 South America Paracetamol Active Pharmaceutical Ingredients Market Under COVID-19
13.2 South America Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Types
13.3 South America Paracetamol Active Pharmaceutical Ingredients Consumption Structure by Application
13.4 South America Paracetamol Active Pharmaceutical Ingredients Consumption Volume by Major Countries
13.4.1 Brazil Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.2 Argentina Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.3 Columbia Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.4 Chile Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.5 Venezuela Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.6 Peru Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
13.4.8 Ecuador Paracetamol Active Pharmaceutical Ingredients Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Paracetamol Active Pharmaceutical Ingredients Business
14.1 Mallinckrodt Pharmaceuticals
14.1.1 Mallinckrodt Pharmaceuticals Company Profile
14.1.2 Mallinckrodt Pharmaceuticals Paracetamol Active Pharmaceutical Ingredients Product Specification
14.1.3 Mallinckrodt Pharmaceuticals Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Anqiu Luan Pharmaceutical
14.2.1 Anqiu Luan Pharmaceutical Company Profile
14.2.2 Anqiu Luan Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Product Specification
14.2.3 Anqiu Luan Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Novacyl
14.3.1 Novacyl Company Profile
14.3.2 Novacyl Paracetamol Active Pharmaceutical Ingredients Product Specification
14.3.3 Novacyl Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 BASF
14.4.1 BASF Company Profile
14.4.2 BASF Paracetamol Active Pharmaceutical Ingredients Product Specification
14.4.3 BASF Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Anhui BBCA Pharmaceuticals
14.5.1 Anhui BBCA Pharmaceuticals Company Profile
14.5.2 Anhui BBCA Pharmaceuticals Paracetamol Active Pharmaceutical Ingredients Product Specification
14.5.3 Anhui BBCA Pharmaceuticals Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Hubei Biocause
14.6.1 Hubei Biocause Company Profile
14.6.2 Hubei Biocause Paracetamol Active Pharmaceutical Ingredients Product Specification
14.6.3 Hubei Biocause Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Xinhua Pharm
14.7.1 Xinhua Pharm Company Profile
14.7.2 Xinhua Pharm Paracetamol Active Pharmaceutical Ingredients Product Specification
14.7.3 Xinhua Pharm Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Granules India Limited
14.8.1 Granules India Limited Company Profile
14.8.2 Granules India Limited Paracetamol Active Pharmaceutical Ingredients Product Specification
14.8.3 Granules India Limited Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Huagang Pharm
14.9.1 Huagang Pharm Company Profile
14.9.2 Huagang Pharm Paracetamol Active Pharmaceutical Ingredients Product Specification
14.9.3 Huagang Pharm Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Hebei Jiheng Pharmaceutical
14.10.1 Hebei Jiheng Pharmaceutical Company Profile
14.10.2 Hebei Jiheng Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Product Specification
14.10.3 Hebei Jiheng Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Zhejiang Kangle Pharmaceutical
14.11.1 Zhejiang Kangle Pharmaceutical Company Profile
14.11.2 Zhejiang Kangle Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Product Specification
14.11.3 Zhejiang Kangle Pharmaceutical Paracetamol Active Pharmaceutical Ingredients Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Paracetamol Active Pharmaceutical Ingredients Market Forecast (2023-2028)
15.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Paracetamol Active Pharmaceutical Ingredients Value and Growth Rate Forecast (2023-2028)
15.2 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Paracetamol Active Pharmaceutical Ingredients Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Paracetamol Active Pharmaceutical Ingredients Consumption Forecast by Type (2023-2028)
15.3.2 Global Paracetamol Active Pharmaceutical Ingredients Revenue Forecast by Type (2023-2028)
15.3.3 Global Paracetamol Active Pharmaceutical Ingredients Price Forecast by Type (2023-2028)
15.4 Global Paracetamol Active Pharmaceutical Ingredients Consumption Volume Forecast by Application (2023-2028)
15.5 Paracetamol Active Pharmaceutical Ingredients Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
Request Sample 
Request Discount 
Inquire Before Buy
